The company reported gross sales of Zanaflex Capsules of $11.8 million and gross sales of Zanaflex of $1.0 million, providing combined gross sales of $12.8 ...
In the same SEC filing, Acorda said it expects to post a loss of $14 million during the fourth quarter, as sales of the muscle relaxant Zanaflex reached $12 ...
... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...
... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...
... hydrocodone and cyclobenzaprine at a Washburn drugstore; the name "Melissa Anderson" to acquire hydrocodone and zanaflex from a Turtle Lake drugstore; ...
He foresees earnings of 90 cents a share in 2010, based on early Fampridine sales and revenue from Acorda's only other product, Zanaflex, which helps MS ...
Acorda's only drug on the market is Zanaflex, a muscle relaxant. The company has two other drug candidates in preclinical development, and a third in the ...
The company reported gross sales of Zanaflex Capsules of $11.8 million and gross sales of Zanaflex of $1.0 million, providing combined gross sales of $12.8 ...
... Therapeutics Inc. said Monday its fourth-quarter loss widened on higher operating expenses, but sales of its drug Zanaflex helped drive revenue higher. ...
The Company's marketed products include Zanaflex Capsules(R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. ...